학술논문
872P - Phase Ib study (COSMIC-021) of cabozantinib in combination with atezolizumab: Results of the dose escalation stage in patients (pts) with treatment-naïve advanced renal cell carcinoma (RCC)
Document Type
Abstract
Source
In Annals of Oncology October 2018 29 Supplement 8
Subject
Language
ISSN
0923-7534